Table 1 Revenue forecast 2007–2012 for the global market of biomarkers by segments in US$ millions (within parenthesis in m€ based on the average currency rates of the year in question)

From: BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres

Market segment

2005

2006

2007

2012

CAGR (%) 2007–2012

Biomarker discovery

2.044 (1.645)

2.339 (1.864)

2.677 (1.957)

5.843 (4.546)

16.9

Clinical trials

450 (362)

625 (498)

512 (374)

1.761 (1.370)

23.5

Molecular diagnostics

1.698 (1.367)

1.95 (1.55)

2.3 (1.7)

5.156 (4.011)

17.5

Total

4.192 (3.375)

4.814 (3.837)

5.589 (4.086)

12.76 (9.93)

18

  1. Abbreviations: CAGR, compound annual growth rate.
  2. Source: BCC Market Research on biomarkers 2007.7